FDA 483 - Navigate Biopharma Services Inc - March 01, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Navigate Biopharma Services Inc in Carlsbad, CA, a medical device sponsor, revealed significant deficiencies in their clinical trial practices. The firm failed to ensure complete informed consent records, with instances of unverified or improperly dated consent forms prior to sample collection. Additionally, the inspection found that IRB review and approval were not secured for an investigational study protocol before patient samples were processed.
ID · e64192c6-0bc6-4e43-8767-7326a6aa7c82